Events

Events
RepliCel Presents its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference
Kanagawa Regeneration and Cell Medical Industry Network Organizers Invite RepliCel to Participate in Foreign Company...
Events
2018 GCFF Shenzhen Investing in North American Innovation Conference
RepliCel is presenting November 29, 2018 to Chinese attendees looking to invest in North American...
Events
Collaboration Meetings with YOFOTO & Participation in the YOFOTO 2018 Global Business Seminar
RepliCel and YOFOTO management will conduct their inaugural joint steering committee meetings on December 4-6,...
Events
2019 EBD Biotech Showcase
RepliCel is excited to have been chosen to present at next year's EBD Biotech Showcase...
Events
2018 EBD Biotech Showcase
RepliCel presented and conducted one-on-one partnering meetings.
Events
2017 EBD Biotech Showcase
RepliCel presented and conducted one-on-one partnering meetings.
Events
2016 EBD Biotech Showcase
RepliCel presented and conducted one-on-one partnering meetings. { "Id": 2026, "Name": "2016 EBD Biotech Showcase",...
Events
RepliCel Executives to Present at 9th World Congress for Hair Research in Miami
Conference brings together hair biologists, dermatologists, cosmetic scientists and leading biotech companies to discuss the...
Events
RepliCel Selected as One of This Year’s Top 20 Public Canadian Technology Companies
Canadian Innovation Exchange (CIX) Public Investor Day November 18 at Toronto’s MaRS Discovery District to...
Events
RepliCel Announces October Presentation and Partnering Meeting Schedule
VANCOUVER, BC – October 8, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP),...
Events
RepliCel Presenting at Two Upcoming Investment and Partnering Forums
A Chinese-based investor forum in Toronto and an aesthetics & dermatology conference in Newport Beach...
Events
RepliCel Presenting at InvestMNT Investor Conference in Minneapolis
Conference attracts investment professionals in the Twin Cities area VANCOUVER, BC – August 3, 2015...
Events
RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC
Conference program to include presentations on the clinical development of RepliCel’s skin rejuvenation, hair regeneration,...
Events
RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference
Clinical trial at the University of British Columbia now recruiting patients VANCOUVER, BC – May...
Events,Press Release
RepliCel Life Sciences Selected to Present at Cavendish Global Health Impact Forum
Unique forum brings together leading family offices and foundations seeking impactful investment and philanthropic opportunities...
Events
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
VANCOUVER, BC – January 20, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),...
Events
RepliCel Life Sciences to Present at Biotech Showcase 2015
Meetings focused on investors, analysts, and potential partners for RCS-01 and RCT-01 cell therapiesVANCOUVER, BC...
Events
RepliCel Life Sciences to Present at World Stem Cell Summit 2014
Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and...
Events
RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum
Japanese meetings to focus on partnering VANCOUVER, BC – October 9, 2014 – RepliCel Life...
Events
RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California
VANCOUVER, BC – October 2, 2014 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),...

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.